The healthcare community is buzzing by retatrutide, a new dual GIP and GLP-1 target that’s showing impressive results in preliminary trials . This treatment works by mimicking natural hormones to regulate appetite and promote feelings of satisfaction , ultimately leading considerable weight decrease. While still under review and not readily avail